| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 296.36 | 178.02 | 138.67 | 139.51 |
| Other Net | -0.49 | 0.32 | 1.48 | 0.11 |
| Diluted Weighted Average Shares | 22.78 | 21.81 | 21.81 | 17.83 |
| Depreciation/ Amortization | 5.61 | 5.82 | 6.50 | 6.54 |
| Operating Income | -289.24 | -171.37 | -126.98 | -125.97 |
| Net Income | -276.34 | -160.75 | -105.08 | -118.27 |
| Income Availableto Com Excl Extra Ord | -276.34 | -160.75 | -105.08 | -118.27 |
| Net Income Before Taxes | -276.34 | -160.75 | -106.08 | -118.27 |
| Net Income After Taxes | -276.34 | -160.75 | -105.08 | -118.27 |
| Income Availableto Com Incl Extra Ord | -276.34 | -160.75 | -105.08 | -118.27 |
| Costof Revenue Total | 1.55 | 1.34 | 0.98 | 0.37 |
| Gross Profit | 5.57 | 5.32 | 10.72 | 13.17 |
| Interest Inc( Exp) Net- Non- Op Total | 13.38 | 10.30 | 19.42 | 7.59 |
| Diluted Net Income | -276.34 | -160.75 | -105.08 | -118.27 |
| Provisionfor Income Taxes | 0.00 | 0.00 | -1.00 | 0.00 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | -276.34 | -160.75 | -105.08 | -118.27 |
| Total Revenue | 7.11 | 6.66 | 11.69 | 13.54 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 7.11 | 6.66 | 11.69 | 13.54 |
| Selling/ General/ Admin Expenses Total | 41.01 | 26.91 | 24.22 | 23.25 |
| Diluted Normalized EPS | -12.13 | -7.37 | -5.04 | -6.97 |
| Research Development | 248.19 | 143.96 | 114.43 | 115.35 |
| Diluted EPS Excluding Extra Ord Items | -12.13 | -7.37 | -4.82 | -6.63 |
| Unusual Expense( Income) | - | 0.00 | -7.46 | -6.00 |
| Gain( Loss)on Saleof Assets | - | - | 0.00 | 0.00 |
Suven Life Sciences Dividend Suven Life Sciences Bonus Suven Life Sciences News Suven Life Sciences AGM Suven Life Sciences Rights Suven Life Sciences Splits Suven Life Sciences Board Meetings Suven Life Sciences Key Metrics Suven Life Sciences Shareholdings Suven Life Sciences Balance Sheet Suven Life Sciences Cashflow Suven Life Sciences Q1 Results Suven Life Sciences Q2 Results Suven Life Sciences Q3 Results Suven Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.